Back to the main directory
Press Release
- AIM ImmunoTech Submits IND and Accompanying Fast Track Application for Phase 2 Trial of Ampligen in Patients with Locally Advanced or Metastatic Late-Stage Pancreatic Cancer by GlobeNewsWire
- InflaRx Awarded up to EUR 43.7 Million (~USD 50.7 Million) Grant by German Government to Advance the Development of Vilobelimab for Treatment of Severe COVID-19 by GlobeNewsWire
- Plus Therapeutics Announces FDA Clearance of Investigational New Drug Application for 186RNL for the Treatment of Leptomeningeal Metastases by GlobeNewsWire
- Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection by GlobeNewsWire
- KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market by GlobeNewsWire
- Alliance Trust PLC - Net Asset Value by GlobeNewsWire
- Virbac : Declaration of the number of shares and voting rights 09/2021 by GlobeNewsWire
- EZ NFT Adds Emerging Nigerian Artist Crixtover Edwin to Growing Roster of Talent by GlobeNewsWire
- Research Finds 82 Percent of American College Students are Concerned About Their Personal Safety by GlobeNewsWire
- Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021 by GlobeNewsWire
- Low-to-Moderate Income Consumers Present $300 Billion Growth Opportunity for the Mortgage Industry by GlobeNewsWire
- DAVIDsTEA Extends Product Offering in Select Loblaw Grocery Locations by GlobeNewsWire
- InnovAge to Announce Fiscal First Quarter 2022 Financial Results and Host Conference Call Tuesday, November 9, 2021 by GlobeNewsWire
- ShotSpotter Sets Third Quarter 2021 Conference Call for Tuesday, November 9, 2021 at 4:30 p.m. ET by GlobeNewsWire
- Standard Uranium Announces Engagement Agreement and 2022 Winter Exploration Plans at its Sun Dog Project by GlobeNewsWire
- X4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U.S. Commercial by GlobeNewsWire
- Kratos Breaks Gigabit Barrier with OpenSpace™ Virtualized Wideband Receivers for Earth Observation Missions by GlobeNewsWire
- AGTC to Present at Upcoming Dry AMD Therapeutic Development Summit by GlobeNewsWire
- Infinera to Announce Fiscal Third Quarter 2021 Financial Results on November 3, 2021 by GlobeNewsWire
- BlueLinx Appoints Ryan Taylor as Vice President of Investor Relations and Treasury by GlobeNewsWire
- VYNE Therapeutics Enrolls First Patient in Clinical Trial of FMX114 for the Treatment of Mild-to-Moderate Atopic Dermatitis by GlobeNewsWire
- Zogenix Reports Granting of Inducement Awards by GlobeNewsWire
- Apollo Highlights Strength of Platform, Strategy, and Growth Trajectory at Investor Day by GlobeNewsWire
- BioSyent Announces Launch of New FeraMAX® Pd Powder 15 by GlobeNewsWire
- Tauriga Sciences Inc. Enters into Strategic Alliance with Psychedelic Water by GlobeNewsWire